Millennium Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.59M | Buy |
634,820
+526,119
| +484% | +$4.64M | ﹤0.01% | 2005 |
|
|
2025
Q1 | $814K | Sell |
108,701
-124,431
| -53% | -$932K | ﹤0.01% | 3077 |
|
|
2024
Q4 | $1.94M | Buy |
233,132
+135,246
| +138% | +$1.13M | ﹤0.01% | 2532 |
|
|
2024
Q3 | $679K | Buy |
+97,886
| New | +$679K | ﹤0.01% | 3136 |
|
|
2023
Q2 | – | Sell |
-153,053
| Closed | -$842K | – | 4830 |
|
|
2023
Q1 | $842K | Buy |
153,053
+63,634
| +71% | +$350K | ﹤0.01% | 3163 |
|
|
2022
Q4 | $410K | Sell |
89,419
-75,884
| -46% | -$348K | ﹤0.01% | 3731 |
|
|
2022
Q3 | $1.03M | Sell |
165,303
-171,944
| -51% | -$1.07M | ﹤0.01% | 3321 |
|
|
2022
Q2 | $1.5M | Buy |
337,247
+16,969
| +5% | +$75.7K | ﹤0.01% | 3109 |
|
|
2022
Q1 | $1.61M | Buy |
+320,278
| New | +$1.61M | ﹤0.01% | 3218 |
|
|
2021
Q2 | – | Sell |
-212,650
| Closed | -$1.96M | – | 5407 |
|
|
2021
Q1 | $1.96M | Buy |
+212,650
| New | +$1.96M | ﹤0.01% | 2835 |
|
|
2018
Q3 | – | Sell |
-9,453
| Closed | -$983K | – | 3816 |
|
|
2018
Q2 | $983K | Buy |
9,453
+8,486
| +878% | +$882K | ﹤0.01% | 2518 |
|
|
2018
Q1 | $122K | Buy |
+967
| New | +$122K | ﹤0.01% | 3224 |
|
|
2017
Q2 | – | Sell |
-936
| Closed | -$73K | – | 3600 |
|
|
2017
Q1 | $73K | Sell |
936
-729
| -44% | -$56.9K | ﹤0.01% | 3125 |
|
|
2016
Q4 | $79K | Buy |
1,665
+100
| +6% | +$4.75K | ﹤0.01% | 3002 |
|
|
2016
Q3 | $112K | Sell |
1,565
-2,185
| -58% | -$156K | ﹤0.01% | 2864 |
|
|
2016
Q2 | $239K | Buy |
3,750
+2,294
| +158% | +$146K | ﹤0.01% | 2600 |
|
|
2016
Q1 | $338K | Buy |
+1,456
| New | +$338K | ﹤0.01% | 2481 |
|
|
2015
Q4 | – | Sell |
-2,029
| Closed | -$629K | – | 3538 |
|
|
2015
Q3 | $629K | Buy |
+2,029
| New | +$629K | ﹤0.01% | 2352 |
|